# PANOVA-3 (NCT03377491)

> Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03377491
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: NovoCure Ltd.
- Conditions: Pancreas Adenocarcinoma
- Interventions: NovoTTF-200T; Gemcitabine; nab paclitaxel
- Enrollment: 571
- Primary outcome: Overall Survival of Subjects Treated With TTFields Concomitant With Gemcitabine and Nab-paclitaxel vs Chemotherapy Alone

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 51
- Podcasts: 10
- YouTube: 8
- X videos: 4

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=panova-3-nct03377491

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03377491", "email": "<work email>"}; the inbox owner confirms by the emailed link.